Read the latest epilepsy news from Epilepsy Society.
€2.5 million genomic research programme brings hope of seizure-free life for people with epilepsy
7 February 2019
A unique collaboration between UK charity Epilepsy Society, and Belgian biopharmaceutical company, UCB, could bring life-changing treatments to people with epilepsy...
Carbagen supply shortage until mid 2019
4 February 2019
We have been informed by the Department of Health and Social Care that some preparations of Carbagen (carbamazepine), will be unavailable until mid to late 2019.
How our research team ran to fund a brand new TMS-EEG chair
30 January 2019
Our Director of Genomics and his research team ran the Royal Parks Half Marathon to raise money for a new TMS-EEG chair and it has arrived.
Epilepsy Society's medical director advises people not to stockpile epilepsy medication
18 January 2019
Epilepsy Society's medical director, Professor Ley Sander is advising people with epilepsy not to stockpile medication themselves.
Anti-epileptic drug brivaracetam is now available for children in Wales
9 January 2019
Children aged four years and older in Wales will have access to the anti-epileptic drug brivaracetam as a new treatment option.
Gov pledges to exempt epilepsy from latest emergency medicine plans post-Brexit
8 January 2019
The Government has promised to exempt people with epilepsy from its most recent plans for potential post-Brexit medicine shortages.
Research is bringing new hope of two different treatments to prevent seizures
8 January 2019
Two new treatments are being developed for people with epilepsy, that may offer hope of better seizure control in the future.
Data shows blood-test can distinguish between epileptic and psychogenic non-epileptic seizures
4 January 2019
A recent study shows a bio-marker based blood test can accurately distinguish epilepsy seizures from psychogenic non-epileptic seizures (PNES).